Skip to the page

Data / Form D filings / BTG PLC

BTG PLC: Form D filings

BTG PLC, a pharmaceuticals company in London, United Kingdom, filed 11 Form D notices with the SEC between 2015 and 2019. The latest, on February 22, 2019, reports $4.1 million sold of an offering with no set size.

Find out what BTG PLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
5 FLEET PLACE, London, United Kingdom, EC4M
Phone
44 20 7575 0000
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
United Kingdom
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1450431

The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 22, 2019AmendmentIndefinite$4,069,671Indefinite0Yet to occursec.gov
Jun 20, 2018AmendmentIndefinite$3,851,342Indefinite26Jun 8, 2015sec.gov
Feb 23, 2018AmendmentIndefinite$4,069,671Indefinite0Yet to occursec.gov
Jun 20, 2017AmendmentIndefinite$3,851,342Indefinite26Jun 8, 2015sec.gov
Feb 24, 2017AmendmentIndefinite$4,069,671Indefinite0Yet to occursec.gov
Jun 21, 2016AmendmentIndefinite$3,851,342Indefinite26Jun 8, 2015sec.gov
Feb 26, 2016AmendmentIndefinite$4,069,671Indefinite0Yet to occursec.gov
Dec 8, 2015New notice$788,002$788,002$03Dec 1, 2015sec.gov
Jun 22, 2015New noticeIndefinite$3,851,342Indefinite26Jun 8, 2015sec.gov
Feb 27, 2015AmendmentIndefinite$4,069,671Indefinite0Yet to occursec.gov
Jan 15, 2015New noticeIndefinite$4,008,102Indefinite0Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Paul MussendenExecutive Officer
Richard WohankaDirector
Duncan KennedyExecutive Officer, Director
Jim O'SheaDirector
Garry WattsDirector
Louise MakinExecutive Officer, Director
Ian MuchDirector
Graham HetheringtonDirector
Susan FodenDirector
Anne ThorburnDirector
Gregory BarrettDirector

Every Form D from the week of Feb 18, 2019 · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what BTG PLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.